Financhill
Back

iShares US Financials ETF Vs. SpringWorks Therapeutics Industry Stock Comparison

Sell
46

IYF
iShares US Financials ETF

Last Price:
$100.21
Seasonality Move:
1.17%
Sell
11

SWTX
SpringWorks Therapeutics

Last Price:
$35.67
Seasonality Move:
5.59%
Sell
46
iShares US Financials ETF (IYF) is a Sell

Is iShares US Financials ETF a Buy, Sell or Hold?

  • The current iShares US Financials ETF [IYF] share price is $99.61. The Score for IYF is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • IYF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $36.99. The Score for SWTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

IYF Stock Price Chart

What is iShares US Financials ETF's stock price today?

  • The iShares US Financials ETF share price today is $99.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IYF is experiencing slight buying pressure.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $36.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing slight selling pressure.

IYF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.41 Sell
Relative Strength Index (14 RSI): 25.06 Sell
Chaikin Money Flow: 73395 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (107.07 - 115.23) Sell
Bollinger Bands (100): (110.52 - 117.96) Sell

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.41 Sell
Relative Strength Index (14 RSI): 31.76 Sell
Chaikin Money Flow: -1228444 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.93 - 51.91) Sell
Bollinger Bands (100): (35.17 - 50.17) Sell

IYF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.01 Sell
20-day SMA: 110.54 Sell
50-day SMA: 114.4 Sell
200-day SMA: 107.79 Sell
8-day EMA: 107.09 Sell
20-day EMA: 110.32 Sell
50-day EMA: 112.47 Sell
200-day EMA: 107.65 Sell

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.32 Sell
20-day SMA: 47.1 Sell
50-day SMA: 47.64 Sell
200-day SMA: 39.14 Sell
8-day EMA: 42.51 Sell
20-day EMA: 45.83 Sell
50-day EMA: 46.19 Sell
200-day EMA: 41.19 Sell

iShares US Financials ETF Earnings Growth & IYF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.

iShares US Financials ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):